These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


456 related items for PubMed ID: 24297641

  • 1. Exacerbations of bipolar disorder triggered by chloroquine in systemic lupus erythematosus--a case report.
    Bogaczewicz J, Sobów T, Bogaczewicz A, Robak E, Bienkowski P, Sysa-Jedrzejowska A, Wozniacka A.
    Lupus; 2014 Feb; 23(2):188-93. PubMed ID: 24297641
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Neuropsychiatric systemic lupus erythematosus presenting as bipolar I disorder with catatonic features.
    Alao AO, Chlebowski S, Chung C.
    Psychosomatics; 2009 Feb; 50(5):543-7. PubMed ID: 19855042
    [Abstract] [Full Text] [Related]

  • 4. Serum brain-derived neurotrophic factor levels as a novel biological marker for the activities of psychiatric symptoms in systemic lupus erythematosus.
    Ikenouchi-Sugita A, Yoshimura R, Okamoto T, Umene-Nakano W, Ueda N, Hori H, Katsuki A, Saito K, Tanaka Y, Nakamura J.
    World J Biol Psychiatry; 2010 Mar; 11(2):121-8. PubMed ID: 20109107
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Psychiatric symptoms induced by hydroxychloroquine.
    Gonzalez-Nieto JA, Costa-Juan E.
    Lupus; 2015 Mar; 24(3):339-40. PubMed ID: 25378239
    [No Abstract] [Full Text] [Related]

  • 10. Treating lupus patients with antimalarials: analysis of safety profile in a single-center cohort.
    Spinelli FR, Moscarelli E, Ceccarelli F, Miranda F, Perricone C, Truglia S, Garufi C, Massaro L, Morello F, Alessandri C, Valesini G, Conti F.
    Lupus; 2018 Sep; 27(10):1616-1623. PubMed ID: 29954281
    [Abstract] [Full Text] [Related]

  • 11. Chloroquine, Hydroxychloroquine and Hearing Loss: A Study in Systemic Lupus Erythematosus Patients.
    Polanski JF, Tanaka EA, Barros H, Chuchene AG, Miguel PTG, Skare TL.
    Laryngoscope; 2021 Mar; 131(3):E957-E960. PubMed ID: 32603516
    [Abstract] [Full Text] [Related]

  • 12. Antimalarial drugs, systemic lupus erythematosus and pregnancy.
    Parke AL.
    J Rheumatol; 1988 Apr; 15(4):607-10. PubMed ID: 3397970
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hydroxychloroquine in pregnant patients with systemic lupus erythematosus.
    Parke A, West B.
    J Rheumatol; 1996 Oct; 23(10):1715-8. PubMed ID: 8895146
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Neuropsychiatric manifestations in systemic lupus erythematosus].
    Alexa ID, Stoica MS, Paraschiv O, Rusu RI.
    Rev Med Chir Soc Med Nat Iasi; 2006 Oct; 110(2):322-5. PubMed ID: 17802940
    [Abstract] [Full Text] [Related]

  • 20. Pregnancy outcome following first trimester exposure to chloroquine.
    Levy M, Buskila D, Gladman DD, Urowitz MB, Koren G.
    Am J Perinatol; 1991 May; 8(3):174-8. PubMed ID: 2029276
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.